Alpha-1 Antitrypsin Deficiency: State of the Art
Release Date: August 27, 2009
Expiration Date: August 27, 2011
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 45 minutes
Description
Cleveland Clinic Respiratory Institute presents the Alpha 1-Antitrypsin Deficiency: State of the Art webcast. It was captured in front of a live audience at the Lung Summit: Update in Pulmonary and Critical Care Medicine.
Objectives
At the conclusion of this activity, the participant will be able to do the following:
- Discuss the epidemiology of alpha-1 antitrypsin deficiency.
- Review the clinical features of patients with alpha-1 antitrypsin deficiency.
- Review therapy of alpha-1 antitrypsin deficiency.
Target Audience
Pulmonologists, general internists, family practice physicians, intensivists, and other allied health practitioners who deal with areas of Respiratory and Critical Care Medicine will find this course valuable in their clinical practice.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Co-Activity Directors
Anita J. Reddy, MD
Respiratory Institute
Cleveland Clinic
Cleveland, Ohio
Joseph G. Parambil, MD
Respiratory Institute
Cleveland Clinic
Cleveland, Ohio
Organizing Committee
Daniel M. Laskowski
Senior Principal Research Engineer
Respiratory Institute & Department of Pathobiology
Cleveland Clinic
Cleveland, Ohio
Herbert P. Wiedemann, MD, MBA
Chairman, Respiratory Institute
Cleveland Clinic
Cleveland, Ohio
Faculty
James K. Stoller, MD, MS
Chair, Education Institute
Head, Respiratory Therapy
Cleveland Clinic
Cleveland, Ohio
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentations, could be perceived as a potential conflict of interest:
| Daniel M. Laskowski | ||
| Consulting | Aerocrine; Talecris Biotherapeutics | |
| James K. Stoller, MD, MS | ||
| Consulting | Arriva Pharmaceuticals | |
| Consulting, Teaching and Speaking | CSL Behring; Talecris Biotherapeutics | |
| Teaching and Speaking | Baxter Health Care; Grifols, Inc. | |
The following faculty members have indicated they have no relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:
Joseph G. Parambil, MD
Anita J. Reddy, MD
Herbert P. Wiedemann, MD, MBA
This CME activity was produced by The Cleveland Clinic Foundation
Respiratory Institute and the Center for Continuing Education.
